| Yolanda Y Campbell, MD | |
|
1600 Medical Center Dr, Suite 4500, Huntington, WV 25701-3656 | |
| (304) 691-1400 | |
| (304) 691-1453 |
| Full Name | Yolanda Y Campbell |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 20 Years |
| Location | 1600 Medical Center Dr, Huntington, West Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881808152 | NPI | - | NPPES |
| 3810012326 | Medicaid | WV |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 23042 (West Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cabell Huntington Hospital Inc | Huntington, WV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Physicians And Surgeons, Inc | 2961315734 | 324 |
News Archive
An analysis by researchers at the Keck School of Medicine of the University of Southern California has found that only 32 percent of medication studies published in top medical journals compare the effectiveness of existing treatments. These studies, known as comparative effectiveness studies, help doctors know which therapies work best and under what circumstances they are most effective.
In hospital trauma centers, where life-or-death decisions are made in seconds, fractions of a second it takes even the best doctors to remember "what's next?" could be pivotal.
Three papers published this month in the open access general medical journal PLoS Medicine investigate how tumors respond to a an important class of drugs used in cancer chemotherapy, known as epidermal growth factor receptor (EGFR) inhibitors.
Neurotech SA announced positive results from an open-label Phase I clinical trial (03-EI-0234) of its lead product, NT-501. NT-501 uses Neurotech's patented Encapsulated Cell Technology (ECT) as a device to deliver ciliary neurotrophic factor (CNTF) to eyes of visually impaired patients with retinitis pigmentosa (RP). Neurotech is a biotechnology company specializing in the development of novel therapeutics to treat diseases of the eye. The company is headquartered in Paris.
For the millions of sufferers of dry eye syndrome, their only recourse to easing the painful condition is to use drug-laced eye drops three times a day.
› Verified 3 days ago
| Entity Name | University Physicians & Surgeons, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730183286 PECOS PAC ID: 2961315734 Enrollment ID: O20031107000331 |
News Archive
An analysis by researchers at the Keck School of Medicine of the University of Southern California has found that only 32 percent of medication studies published in top medical journals compare the effectiveness of existing treatments. These studies, known as comparative effectiveness studies, help doctors know which therapies work best and under what circumstances they are most effective.
In hospital trauma centers, where life-or-death decisions are made in seconds, fractions of a second it takes even the best doctors to remember "what's next?" could be pivotal.
Three papers published this month in the open access general medical journal PLoS Medicine investigate how tumors respond to a an important class of drugs used in cancer chemotherapy, known as epidermal growth factor receptor (EGFR) inhibitors.
Neurotech SA announced positive results from an open-label Phase I clinical trial (03-EI-0234) of its lead product, NT-501. NT-501 uses Neurotech's patented Encapsulated Cell Technology (ECT) as a device to deliver ciliary neurotrophic factor (CNTF) to eyes of visually impaired patients with retinitis pigmentosa (RP). Neurotech is a biotechnology company specializing in the development of novel therapeutics to treat diseases of the eye. The company is headquartered in Paris.
For the millions of sufferers of dry eye syndrome, their only recourse to easing the painful condition is to use drug-laced eye drops three times a day.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Yolanda Y Campbell, MD 1600 Medical Center Dr, Suite 4500, Huntington, WV 25701-3656 Ph: (304) 691-1400 | Yolanda Y Campbell, MD 1600 Medical Center Dr, Suite 4500, Huntington, WV 25701-3656 Ph: (304) 691-1400 |
News Archive
An analysis by researchers at the Keck School of Medicine of the University of Southern California has found that only 32 percent of medication studies published in top medical journals compare the effectiveness of existing treatments. These studies, known as comparative effectiveness studies, help doctors know which therapies work best and under what circumstances they are most effective.
In hospital trauma centers, where life-or-death decisions are made in seconds, fractions of a second it takes even the best doctors to remember "what's next?" could be pivotal.
Three papers published this month in the open access general medical journal PLoS Medicine investigate how tumors respond to a an important class of drugs used in cancer chemotherapy, known as epidermal growth factor receptor (EGFR) inhibitors.
Neurotech SA announced positive results from an open-label Phase I clinical trial (03-EI-0234) of its lead product, NT-501. NT-501 uses Neurotech's patented Encapsulated Cell Technology (ECT) as a device to deliver ciliary neurotrophic factor (CNTF) to eyes of visually impaired patients with retinitis pigmentosa (RP). Neurotech is a biotechnology company specializing in the development of novel therapeutics to treat diseases of the eye. The company is headquartered in Paris.
For the millions of sufferers of dry eye syndrome, their only recourse to easing the painful condition is to use drug-laced eye drops three times a day.
› Verified 3 days ago
Rafael Evencio Molina, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1630 13th Ave, Huntington, WV 25701 Phone: 304-697-2014 | |
Herbert Myers, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1630 13th Ave, Huntington, WV 25701 Phone: 304-697-2014 | |
Benjamin M Edwards, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1600 Medical Center Dr, Suite 4500, Huntington, WV 25701 Phone: 304-691-1400 Fax: 304-691-1453 | |
Richard Booth Jr., M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1630 13th Ave, Huntington, WV 25701 Phone: 304-697-2014 | |
Dr. Jennie Lee Yoost, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1600 Medical Center Dr Ste 4500, Huntington, WV 25701 Phone: 304-691-1400 | |
William N Burns, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1600 Medical Center Dr, Suite 4500, Huntington, WV 25701 Phone: 304-691-1400 Fax: 304-691-1453 | |
Carolyn E. Clark, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1124 19th St, Huntington, WV 25701 Phone: 304-529-4117 Fax: 304-529-4110 |